MDT

88.75

+2.73%↑

A

116.89

+2.76%↑

VEEV

166.33

-3.59%↓

HQY

81.95

+1.22%↑

TLRY

6.75

+4.65%↑

MDT

88.75

+2.73%↑

A

116.89

+2.76%↑

VEEV

166.33

-3.59%↓

HQY

81.95

+1.22%↑

TLRY

6.75

+4.65%↑

MDT

88.75

+2.73%↑

A

116.89

+2.76%↑

VEEV

166.33

-3.59%↓

HQY

81.95

+1.22%↑

TLRY

6.75

+4.65%↑

MDT

88.75

+2.73%↑

A

116.89

+2.76%↑

VEEV

166.33

-3.59%↓

HQY

81.95

+1.22%↑

TLRY

6.75

+4.65%↑

MDT

88.75

+2.73%↑

A

116.89

+2.76%↑

VEEV

166.33

-3.59%↓

HQY

81.95

+1.22%↑

TLRY

6.75

+4.65%↑

Search

Medpace Holdings Inc

Closed

SectorHealthcare

518.97 2.12

Overview

Share price change

24h

Current

Min

506.12

Max

524.88

Key metrics

By Trading Economics

Income

24M

135M

Sales

49M

708M

P/E

Sector Avg

32.503

66.418

Profit margin

19.074

Employees

6,200

EBITDA

14M

164M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+4.49% upside

Dividends

By Dow Jones

Next Earnings

22 kwi 2026

Market Stats

By TradingEconomics

Market Cap

-2.5B

14B

Previous open

516.85

Previous close

518.97

News Sentiment

By Acuity

67%

33%

318 / 349 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Medpace Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

23 paź 2025, 15:15 UTC

Earnings

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back -- Barrons.com

Peer Comparison

Price change

Medpace Holdings Inc Forecast

Price Target

By TipRanks

4.49% upside

12 Months Forecast

Average 518.25 USD  4.49%

High 582 USD

Low 419 USD

Based on 9 Wall Street analysts offering 12 month price targets forMedpace Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

4

Buy

5

Hold

0

Sell

Technical Score

By Trading Central

300 / 302.88Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

318 / 349 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
help-icon Live chat